Federated Hermes’s ProPhase Labs PRPH Stock Holding History

Federated Hermes’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-221	Closed	-$4K	–	2044
2014 Q2	$4K	Buy	+221	New	+$4.09K	﹤0.01%	1865

Other funds holding PRPH

VIP

Vantage Investment Partners Kansas City, Missouri $1.45B AUM 18.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Federated Hermes's PRPH Position: Q3 2014 in Review

Federated Hermes sold out of ProPhase Labs (PRPH) in Q3 2014, closing a stake of 221 shares — an estimated $4K sold.

Federated Hermes first reported a position in PRPH in Q2 2014 and held it in 1 quarter. The position peaked at $4K in Q2 2014. 18 funds tracked by Wall St. Rank hold PRPH as of Q3 2014.

Federated Hermes reported no remaining ProPhase Labs position as of Q3 2014 after selling out during the quarter.
Federated Hermes sold 221 ProPhase Labs shares in Q3 2014, an estimated $4K.
Federated Hermes first reported a position in ProPhase Labs in Q2 2014 and held it in 1 quarter.
Federated Hermes's ProPhase Labs position peaked at $4K in Q2 2014.
18 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2014.

Based on Federated Hermes's 13F filing for Q3 2014, filed 12 Nov 2014.